Abstract:The DNA binding and cross-linking modes of a trinuclear platinum Complex [Pt3Cl3(hptab)][ClO4](3) (1; hptab = N,N,N',N',N '',N ''-hexakis(2-pyridylmethyl)-1,3,5-tris(aminomethyl)benzene) and its dinuclear analogue [Pt2Cl2(m-tpxa)]Cl-2 (2; m-tpxa = N,N,N',N'-tetra(2-pyridylmethyl)-m-xylylene diamine) are reported and compared. The adducts of 1 and 2 with 18-mer duplex N1, 5'-d(GAAGAAGTCA-CAAAATGT)-3'center dot 5'-d(ACATTTTGT-GACTTCTTC)-3', have been characterized by means of denaturing polyacrylamide gels, Maxam-Gilbert sequencing, and MALDI-TOF mass spectrometry combined with enzymatic degradation to obtain insights into Structural features responsible for the differences in their antitumor activities. The cytotoxic-active complex 1 readily forms various DNA adducts, such as through 1,3- and 1,4-intrastrand cross-links, and in particular, the unique and unprecedented interstrand cross-linked triadducts. In contrast, the cytotoxic-inactive complex 2 preferentially forms 1,4-intrastrand rather than 1,3-intra- and -interstrand cross-links. Digestion of the DNA adducts of 1 shows that the cleavage is completely blocked at one nucleotide before the cross-linked guanine residues on the opposite strand, a feature that appears to be unprecedented in antitumor platinum complexes. In the case of 2, the cleavage bypasses the first platinated guanine site and stops at one nucleotide prior to the second platinated site, confirming that very few 1,3-intrastrand cross-links are formed by 2. These results are supported by molecular-modeling studies of intra- and interstrand cross-links Of duplex NI with 1 and 2. The remarkable differences between 1 and 2 in DNA binding and cross-linking provide mechanistic insights into their different cytotoxicity against the tumor cell lines; these insights are useful for designing future antitumor agents.

Dna-Templated Platinum Nanocluster Deposition

Structural characterization of nanoparticles from thermoresponsive poly(N-isopropylacrylamide)-DNA conjugate.

DNA-templated preparation of palladium nanoparticles and their application

DNA Interaction of Dioxycyclobutenedione-(1,2-cyclohexanediamine) Platinum(ii) Complex with Potential Anticancer Activity.

The interactions of cisplatin and DNA studied by atomic force microscopy.

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

A CNDO/2 Study on Bonding Mechanism of Cis-Dichlorodiammine Platinum (II) with DNA

Dna-Binding Property and Antitumor Activity of A Cyclam Bridged Dinuclear Platinum(Ii) Complex

Crystal Structure, DNA-binding Ability and Cytotoxic Activity of Platinum(ii) 2,2′-Dipyridylamine Complexes

Dna Cross-Linking Patterns Induced by an Antitumor-Active Trinuclear Platinum Complex and Comparison with Its Dinuclear Analogue

Nmr-Study on the Solution Structure of D-Tgggt

DNA Nanostructures as Pt(IV) Prodrug Delivery Systems to Combat Chemoresistance

The Role of Bridging Ligands in Determining DNA-binding Ability and Cross-Linking Patterns of Dinuclear Platinum(ii) Antitumour Complexes.

Molecular Dynamics Studies of Changes in the DNA- Structure as Result of Interactions with Cisplatin

Structural changes of linear DNA molecules induced by cisplatin.

Nanopore Sequencing Accurately Identifies the Cisplatin Adduct on DNA.

A New Platinum Anticancer Drug Forms a Highly Stereoselective Adduct with Duplex DNA

Binuclear Monofunctional Platinum(ii) Complexes Formed by Hexaazamacrocyclic Bisdien Ligands: Crystal Structure, DNA Binding and Cytotoxicity Studies

A DNA-Based Nano Carrier for Efficient Cancer Therapy